In addition to demographic, clinical and therapeutic factors, the levels of antinucleosome, anti-C1q antibodies and several cytokines like MCP-1, measured in serum and urine, can be estimated as potential risk factors for organ damage in SLE patients. Here, CCL2 is linked to systemic lupus erythematosus.